Reduction in mobility and COVID-19 transmission

Global absence and targeting of protective immune states in severe COVID-19

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial

Alzheimer Europe continues to develop and improve its Clinical Trials Watch (CTW), an innovative online resource providing up-to-date accessible information on clinical trials currently recruiting participants in a least one European country.

In late 2019, the European Brain Council (EBC) launched the development of the Shared European Brain Research Agenda (SEBRA).

For March 2021, we have selected: Krienke C. et al., A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 2021; 371: 145-153. doi: 10.1126/science.aay3638.

Clinical Fellowship Reports 2020

We would like to inform you of the third EMA public stakeholder meeting on the approval, safety monitoring and impact of COVID-19 vaccines in the EU to be held virtually on 26 March 2021 from 13:00 to 15:15 CET.

For March 2021, we have selected: Lynch D.R. et al. Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol 2021; 89:212-225. doi: 10.1002/ana.25934.

Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Prof. Raad Shakir, CBE

Country of the Month for March 2021 is Lithuania

This year, the EAN Regional Teaching Course also has to adapt to changes. We are happy to announce the first Virtual Regional Teaching Course (RTC in Moscow, Russia 2021 - Virtual - ean.org ) on April 15-17, 2021.

Clinical Fellowship Reports 2019